High Mobility Group 20B (HMG20B) Peptide
HMG20B
Reactivity: Human, Mouse
Host: Synthetic
BP, WB
-
- Target See all HMG20B products
- HMG20B (High Mobility Group 20B (HMG20B))
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-HMG20B antibody (Catalog #: ARP37058_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HMG20B (High Mobility Group 20B (HMG20B))
- Background
-
Hmg20b is the component of a BHC histone deacetylase complex that contains HDAC1, HDAC2, HMG20B/BRAF35, AOF2/LSD1, RCOR1/CoREST and PHF21A/BHC80. Hmg20b is required for correct progression through G2 phase of the cell cycle and entry into mitosis Hmg20b is also required for RCOR1/CoREST mediated repression of neuronal specific gene promoters.
Alias Symbols: Hmgx2, BRAF35, Hmgxb2, AW610687, Smarce1r
Protein Size: 317 - Molecular Weight
- 35 kDa
- Gene ID
- 15353
- NCBI Accession
- NM_010440, NP_034570
- UniProt
- Q9Z104
-
You are here:
